You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. An epitope focused nanoparticle vaccine for MRSA and biodefense

    SBC: VLP BIOTECH, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Overall Staphylococcus aureus is a gram positive bacteria which possesses a multitude of virulence factors It is a frequent and severe pathogen in hospitals and of increasing concern in the community where it results in severe skin infections pneumonia bacterial endocarditis and sepsis A significant proportion of these infections are the result of methici ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications

    SBC: GENECAPTURE            Topic: CBD15C001

    The modern warfighter faces the constant threat of endemic infections, multi-drug resistant bacteria and Biological Warfare Agents. In order to provide accurate front-line treatment that will curtail the overuse of antibiotics, a rapid and robust molecula

    STTR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense
  3. Optimization of the Production and Isolation of the Novel Antifungal Occidiofungin

    SBC: Sano Chemicals, Inc.            Topic: NIAID

    DESCRIPTION provided by applicant Occidiofungin is a cyclic nonribosomally synthesized antifungal peptide with submicromolar fungicidal activity against a broad spectrum of fungi Occidiofungin is produced by the Gram negative bacterium Burkholderia contaminans From our structural characterization studies occidiofungin was determined to have a unique chemical composition Our studies have als ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Protection and Treatment of the Ocular Surface Barrier

    SBC: Proteris Biotech, Inc.            Topic: N

    DESCRIPTION provided by applicant Dry eye a group of disorders that affects million people over the age of in the USA today is characterized by inadequate hydration and lubrication of the ocular surface The final common pathway for all types of dry eye is disruption of the ocular surface barrier which can be assessed by quantifying uptake of water soluble dyes applied topically to the ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  5. STTR Phase I: Advanced Computational System for Assessing Genetic Provenance in Crop Plants and its Practical Applications

    SBC: Prosapia Genetics LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be the development of a highly accurate genotype analysis technique and the computational pipeline for assessing genetic provenance in crop plants. The commercial potential of the proposed products and services is based on the need to increase crop yield and accelerate breeding programs. The prop ...

    STTR Phase I 2016 National Science Foundation
  6. STTR Phase I: An integrated platform for the analysis of patient health record data to enable predictive clinical decision support

    SBC: DASCENA            Topic: SH

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to reduce preventable patient readmissions, streamline triage, and detect multi-organ diseases early. Currently, failures of care delivery and care coordination, overtreatment, and administrative complexity cost the American healthcare system an estimated 300 billion dollars per year, and a ...

    STTR Phase I 2016 National Science Foundation
  7. STTR Phase I: An On-Demand Protein Engineering Platform

    SBC: SYNVITROBIO, INC.            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be the development of a platform technology for high-throughput protein expression. The current standard for expressing panels of proteins involves extensive bioinformatics, cloning, in vivo expression, and assays. This method takes significant expertise in disparate fields, and weeks to months o ...

    STTR Phase I 2016 National Science Foundation
  8. STTR Phase I: A robotic system for performing biopsies and therapeutic interventions while the patient is inside an MRI scanner

    SBC: GUIDABOT, LLC            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is that it will benefit healthcare by improving patient outcome and procedural efficiency. While Magnetic Resonance Imaging (MRI) is increasingly used to guide interventions, this is challenged by the limited access to the patient inside the scanners. Current practices - either removing the pa ...

    STTR Phase I 2016 National Science Foundation
  9. STTR Phase I: Authoring Tools for Virtual Role-Play

    SBC: Alelo Tlt, LLC            Topic: EA

    This SBIR Phase I project will develop a revolutionary new tool for creating engaging language-learning content. Educational publishers, teachers, and even students will be able to create artificially intelligent "virtual role-players" that converse in foreign languages, responding to either speech or text input. Large-scale on-line communities of educators will be able to create, customize, and s ...

    STTR Phase I 2016 National Science Foundation
  10. STTR Phase I: Biomanufacture of Novel Heparan Sulfate Glycosaminoglycans

    SBC: TEGA THERAPEUTICS, INC.            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be to commercialize novel sugar polymers known as glycosaminoglycan (GAGs) for a variety of important medical applications. GAGs are key components in a number of important physiologic and pathophysiologic conditions (e.g., tumor angiogenesis, thrombosis); however, developing a detailed understan ...

    STTR Phase I 2016 National Science Foundation
US Flag An Official Website of the United States Government